{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:44:10Z","timestamp":1791380650153,"version":"4.3.3"},"reference-count":26,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Antipsychotics might be thought of as pleuripotent broad-spectrum psychotropics, given the versatile pharmacological portfolio, with a multitude of uses on clinical grounds, albeit off-label. Herein, authors would touch briefly on the general pharmacology and therapeutic potential of antipsychotics. Nonetheless, It should be borne in mind, that the level of evidence supporting the use of antipsychotics in many of these unlicensed indications remain, at large, flimsy, and other agents with solid evidence-base should be explored first.<\/jats:p>","DOI":"10.64719\/pb.16602","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:16:27Z","timestamp":1773260187000},"page":"163-169","source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotics\u2014"],"prefix":"10.64719","volume":"56","author":[{"given":"Ahmed","family":"Naguy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saxby","family":"Pridmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Y","family":"Abuzeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi","family":"Alamiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Leucht S, Priller J, Davis JM. Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application. Am J Psychiatry. 2024;181(10):865\u2013878.","DOI":"10.1176\/appi.ajp.20240738"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mailman RB, Murthy V. Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des. 2010;16(5):488\u2013501.","DOI":"10.2174\/138161210790361461"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG. Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol. 2019;39:31\u201359.","DOI":"10.1007\/s10571-018-0632-3"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Naguy A, Pridmore S, Alamiri B. The future of schizophrenia psychopharmacotherapy: more antipsychotic atypicality? Guess So! Psychopharmacol Bull. 2023;53(1):55\u201357.","DOI":"10.64719\/pb.4462"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Naguy A. Levomilnacipran for negative symptom domain schizophrenia. Prim Care Companion CNS Disord. 2021;23(6):20l02873.","DOI":"10.4088\/PCC.20l02873"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Naguy A, Allami S, Abuzeid MY, Alamiri B. Successful ziprasidone treatment for resistant attention-deficit\/hyperactivity disorder and provisional motor tic disorder. Am J Ther. 2022;29(4):486\u2013488.","DOI":"10.1097\/MJT.0000000000001371"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2016;64(4):705\u2013714.","DOI":"10.1111\/jgs.14076"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"van Schalkwyk GI, Beyer C, Johnson J, Deal M, Bloch MH. Antipsychotics for aggression in adults: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:452\u2013458.","DOI":"10.1016\/j.pnpbp.2017.07.019"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hocking CM, Kichenadasse G. Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review. Support Care Cancer. 2014;22(4):1143\u20131151.","DOI":"10.1007\/s00520-014-2138-y"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Alamiri B, Naguy A. Methylphenidate-induced persistent hiccups in a child with ADHD relieved by add-on risperidone. Am J Ther. 2020;28(6):e706\u2013e707.","DOI":"10.1097\/MJT.0000000000001268"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Naguy A. Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more. Ther Adv Psychopharmacol. 2016;6(6):384\u2013385.","DOI":"10.1177\/2045125316672545"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lin CY, Chiang CH, Tseng MM, Tam KW, Loh EW. Effects of quetiapine on sleep: a systematic review and meta-analysis of clinical trials. Eur Neuropsychopharmacol. 2023;67:22\u201336.","DOI":"10.1016\/j.euroneuro.2022.11.008"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Naguy A. Successful use of sertindole for severe behavioral dyscontrol in a pediatric case of syndromic autism spectrum disorder. J Child Adolesc Psychopharmacol. 2017;27(5):471\u2013472.","DOI":"10.1089\/cap.2016.0182"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Naguy A. A Comment on \u201cAdd-on aripiprazole for atypical antipsychotic-induced, clinically significant hyperprolactinemia\u201d. Indian J Psychol Med. 2018;40(3):299\u2013300.","DOI":"10.4103\/IJPSYM.IJPSYM_47_18"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Naguy A. Antipsychotic polypharmacy in psychiatric practice: is it really doomed? Australas Psychiatry. 2017;25(2):200\u2013201.","DOI":"10.1177\/1039856216671652"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Naguy A, Naguy C, Sabir S. Psychopharmacotherapy of eating disorders-what works for whom? Psychopharmacol Bull. 2025;55(4):1\u20134.","DOI":"10.64719\/pb.4462"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Naguy A, Moodliar-Rensburg S, Alamiri B. Clozapine-associated hypothyroidism. Am J Ther. 2020;28(6):e722\u2013e724.","DOI":"10.1097\/MJT.0000000000001244"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Naguy A. Antipsychotics and OCD: boon or bane? Am J Ther. 2017;39(6):830\u2013831.","DOI":"10.4103\/IJPSYM.IJPSYM_236_17"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Naguy A, AlAwadhi D. Psychopharmacology of suicide. Asian J Psychiatr. 2018;36:100\u2013101.","DOI":"10.1016\/j.ajp.2018.07.007"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Naguy A, Naguy C. Trichotieromania and alopecia areata triggered by aripiprazole-methylphenidate combo in an autistic child: the nexus of impulsivity-compulsivity. Psychopharmacol Bull. 2022;52(2):157\u2013160.","DOI":"10.64719\/pb.4437"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Naguy A, Alhazeem H. Clozapine prescripers-dogmatic or pragmatic? Psychopharmacol Bull. 2024;54(2):46\u201350.","DOI":"10.64719\/pb.4490"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Roldan CJ, Chambers KA, Paniagua L, Patel S, Cardenas-Turanzas M, Chathampally Y. Randomized controlled double-blind trial comparing haloperidol combined with conventional therapy to conventional therapy alone in patients with symptomatic gastroparesis. Acad Emerg Med. 2017;24(11):1307\u20131314.","DOI":"10.1111\/acem.13245"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Yang C-C, Liang C-S, Chu C-W. Combination of quetiapine immediate release and XR for H1-antihistamine-refractory chronic spontaneous urticaria comorbid with depressive disorder: a case report. Am J Ther. 2019;26(6):e727\u2013e728.","DOI":"10.1097\/MJT.0000000000000877"},{"key":"ref24","unstructured":"Naguy A, Pridomre S, Alenezi H, Alamiri B. Psychopathology down the memory lane: ekbom\u2019s syndrome(s) Clin Schizophr Relat Psychoses. 2022;16(3):1\u20132."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Naguy A, Sing A, AlDarweesh FQM, Alamiri B. Possible toxic serotonin syndrome in an adolescent with obsessive-compulsive disorder precipitated by esomeprazole. Prim Care Companion CNS Disord. 2022;24(4):21cr03096.","DOI":"10.4088\/PCC.21cr03096"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Boyd-Kimball D, Gonczy K, Lewis B, Mason T, Siliko N, Wolfe J. Classics in chemical neuroscience: chlorpromazine. ACS Chem Neurosci. 2019;10(1):79\u201388.","DOI":"10.1021\/acschemneuro.8b00258"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:36:52Z","timestamp":1791315412000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/antipsychotics-therapeutic-salve-or-iatrogenic-thorn\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.16602","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}